Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.700
-0.100 (-2.08%)
Jun 27, 2025, 4:00 PM - Market closed
Y-mAbs Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$17.55
Upside
+273.40%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $20 → $15 | Buy | Maintains | $20 → $15 | +219.15% | May 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +134.04% | May 19, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +197.87% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +325.53% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $12 | Strong Buy | Maintains | $22 → $12 | +155.32% | Mar 21, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +155.32% | Mar 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +282.98% | Mar 5, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $11 → $7 | Sell | Maintains | $11 → $7 | +48.94% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +368.09% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +261.70% | Dec 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +389.36% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +368.09% | Nov 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $23 | Buy | Reiterates | $23 | +389.36% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $20 | Buy | Reiterates | $20 | +325.53% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $20 | Buy | Initiates | $20 | +325.53% | Aug 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.